{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:26:37Z","timestamp":1792074397765,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ccc.2025.05.007","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:22:10Z","timestamp":1751545330000},"page":"641-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacology of Alpha-2 Agonists Applied to Sedation, Sleep, and Analgesia"],"prefix":"10.1016","volume":"41","author":[{"given":"Cathrine Anne","family":"McKenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Simon","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ccc.2025.05.007_bib1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00134-016-4297-4","article-title":"Comfort and patient-centred care without excessive sedation: the eCASH concept","volume":"42","author":"Vincent","year":"2016","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ccc.2025.05.007_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/ALN.0000000000001378","article-title":"Intensive care unit delirium: a review of diagnosis, prevention, and treatment","volume":"125","author":"Hayhurst","year":"2016","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.ccc.2025.05.007_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jama.1980.03300300021018","article-title":"Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment","volume":"243","author":"Gold","year":"1980","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/chi.0b013e31815d9af7","article-title":"Clonidine for attention-deficit\/hyperactivity disorder: I. Efficacy and tolerability outcomes","volume":"47","author":"Palumbo","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ccc.2025.05.007_bib5","doi-asserted-by":"crossref","unstructured":"CADTH Health Technology Review. Review of guidelines on clonidine for various indications: rapid review. Ottawa (ON): Canadian agency for drugs and technologies in health; 2024.","DOI":"10.51731\/cjht.2024.955"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib6","first-page":"13","article-title":"Dexmedetomidine: a novel sedative-analgesic agent","volume":"14","author":"Gertler","year":"2001","journal-title":"SAVE Proc"},{"issue":"11","key":"10.1016\/j.ccc.2025.05.007_bib7","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDra2300347","article-title":"Sedation in the ICU","volume":"3","author":"Northam","year":"2024","journal-title":"NEJM Evid"},{"issue":"9","key":"10.1016\/j.ccc.2025.05.007_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00134-021-06490-3","article-title":"Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis","volume":"47","author":"Burry","year":"2021","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib9","doi-asserted-by":"crossref","first-page":"436.e1","DOI":"10.1016\/j.jcrc.2014.11.006","article-title":"A web-based survey of United Kingdom sedation practice in the intensive care unit","volume":"30","author":"Yassin","year":"2015","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13054-016-1532-x","article-title":"National survey and point prevalence study of sedation practice in UK critical care","volume":"20","author":"Richards-Belle","year":"2016","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s40140-021-00446-5","article-title":"Sedation in the intensive care unit","volume":"11","author":"Page","year":"2021","journal-title":"Curr Anesthesiol Rep"},{"key":"10.1016\/j.ccc.2025.05.007_bib12","series-title":"xPharm: the comprehensive pharmacology reference","first-page":"1","article-title":"Alpha-2 adrenoceptors","author":"Bylund","year":"2007"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth Prog"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-6576.2007.01537.x","article-title":"Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep","volume":"52","author":"Huupponen","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"issue":"11","key":"10.1016\/j.ccc.2025.05.007_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2012.304","article-title":"Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials","volume":"307","author":"Jakob","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccc.2025.05.007_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00001503-200110000-00009","article-title":"Alpha(2) receptors and agonists in pain management","volume":"14","author":"Smith","year":"2001","journal-title":"Curr Opin Anaesthesiol"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.anclin.2017.01.009","article-title":"Alpha-2 agonists","volume":"35","author":"Nguyen","year":"2017","journal-title":"Anesthesiol Clin"},{"issue":"4","key":"10.1016\/j.ccc.2025.05.007_bib18","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00000542-200004000-00008","article-title":"Alpha2 adrenoceptors in pain modulation: which subtype should be targeted to produce analgesia?","volume":"92","author":"Maze","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccc.2025.05.007_bib20","series-title":"Alpha(\u03b1) 2-Adrenergic agonists in pain treatment","author":"Bantel","year":"2007"},{"key":"10.1016\/j.ccc.2025.05.007_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.549908","article-title":"Abnormal sleep, circadian rhythm disruption, and delirium in the ICU: are they related?","volume":"11","author":"Daou","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","article-title":"The effects of increasing plasma concentrations of dexmedetomidine in humans","volume":"93","author":"Ebert","year":"2000","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.ccc.2025.05.007_bib23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine","volume":"56","author":"Weerink","year":"2017","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.ccc.2025.05.007_bib24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/00000542-199212000-00014","article-title":"Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes","volume":"77","author":"Bloor","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccc.2025.05.007_bib25","article-title":"Effects of dexmedetomidine on immune cells: a narrative review","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s13054-019-2690-4","article-title":"The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: a systematic review of animal and human studies","volume":"23","author":"Flanders","year":"2019","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.ccc.2025.05.007_bib27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/bph.15363","article-title":"Emerging benefits and drawbacks of \u03b1(2) -adrenoceptor agonists in the management of sepsis and critical illness","volume":"178","author":"Lankadeva","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.ccc.2025.05.007_bib28","article-title":"Alpha-2 adrenergic agonists for the prevention of shivering following general anaesthesia","volume":"2015","author":"Lewis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ccc.2025.05.007_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183154","article-title":"Dexmedetomidine as a neuraxial adjuvant for prevention of perioperative shivering: meta-analysis of randomized controlled trials","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jcph.776","article-title":"Antipyretic effect of clonidine in intensive care unit patients: a nested observational study","volume":"57","author":"Mokhtari","year":"2017","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ccc.2025.05.007_bib31","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1213\/ANE.0000000000002353","article-title":"Dexmedetomidine-associated hyperthermia: a series of 9 cases and a review of the literature","volume":"125","author":"Kr\u00fcger","year":"2017","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.ccc.2025.05.007_bib32","article-title":"Dexmedetomidine-associated hyperpyrexia in three critically ill patients with coronavirus disease 2019","volume":"2","author":"Czepiel","year":"2020","journal-title":"Crit Care Explor"},{"issue":"12","key":"10.1016\/j.ccc.2025.05.007_bib33","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.clinthera.2009.12.008","article-title":"Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin","volume":"31","author":"Kelesidis","year":"2009","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/bean.2000.0079","article-title":"A historical perspective: development of clonidine","volume":"14","author":"Helmut","year":"2000","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00609752","article-title":"Pharmacokinetics and side-effects of clonidine","volume":"13","author":"Ker\u00e4nen","year":"1978","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ccc.2025.05.007_bib36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/clpt.1981.230","article-title":"Plasma clonidine concentration and pharmacologic effect","volume":"30","author":"Hogan","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.ccc.2025.05.007_bib37","article-title":"Topical clonidine for neuropathic pain","volume":"8","author":"Wrzosek","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ccc.2025.05.007_bib38","article-title":"Clonidine for smoking cessation","volume":"2004","author":"Gourlay","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccc.2025.05.007_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154433","article-title":"Research letter: Clonidine is associated with faster first resolution of incident ICU delirium than antipsychotics","volume":"79","author":"Wu","year":"2024","journal-title":"J Crit Care"},{"issue":"4","key":"10.1016\/j.ccc.2025.05.007_bib40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/0970-9185.74581","article-title":"Clonidine in adults as a sedative agent in the intensive care unit","volume":"26","author":"Jamadarkhana","year":"2010","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib41","first-page":"223","article-title":"Clinical efficacy and pharmacokinetics of clonidine in hemodialysis and renal insufficiency","volume":"94","author":"Hulter","year":"1979","journal-title":"J Lab Clin Med"},{"issue":"8","key":"10.1016\/j.ccc.2025.05.007_bib42","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/bcp.14273","article-title":"Optimising the dose of clonidine to achieve sedation in intensive care unit patients with population pharmacokinetics","volume":"86","author":"Cloesmeijer","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ccc.2025.05.007_bib43","first-page":"e257200","article-title":"Dexmedetomidine- or clonidine-based sedation compared with propofol in critically ill patients: the A2B randomized clinical trial","author":"Walsh","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13054-017-1610-8","article-title":"Clonidine for sedation in the critically ill: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2017","journal-title":"Crit Care"},{"issue":"Suppl 1","key":"10.1016\/j.ccc.2025.05.007_bib45","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/00005344-198000021-00004","article-title":"Pharmacokinetics of clonidine","volume":"2","author":"Lowenthal","year":"1980","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"10.1016\/j.ccc.2025.05.007_bib46","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00134-024-07619-w","article-title":"Low-dose clonidine infusion to improve sleep in postoperative patients in the high-dependency unit. A randomised placebo-controlled single-centre trial","volume":"50","author":"Liu","year":"2024","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5492\/wjccm.v12.i1.18","article-title":"Clonidine use during dexmedetomidine weaning: a systematic review","volume":"12","author":"Rajendraprasad","year":"2023","journal-title":"World J Crit Care Med"},{"key":"10.1016\/j.ccc.2025.05.007_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jclinane.2017.02.003","article-title":"What is the place of clonidine in anesthesia? Systematic review and meta-analyses of randomized controlled trials","volume":"38","author":"Sanchez Munoz","year":"2017","journal-title":"J Clin Anesth"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib49","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/ALN.0b013e3181aae897","article-title":"Clonidine as an adjuvant to local anesthetics for peripheral nerve and plexus blocks: a meta-analysis of randomized trials","volume":"111","author":"P\u00f6pping","year":"2009","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib50","first-page":"E193","article-title":"A comprehensive review of the use of alpha 2 agonists in spinal anesthetics","volume":"25","author":"Schwartz","year":"2022","journal-title":"Pain Physician"},{"key":"10.1016\/j.ccc.2025.05.007_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1043956","article-title":"A comprehensive overview of clinical research on dexmedetomidine in the past 2 decades: a bibliometric analysis","volume":"14","author":"Kong","year":"2023","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13613-022-00985-y","article-title":"Practices in sedation, analgesia, mobilization, delirium, and sleep deprivation in adult intensive care units (SAMDS-ICU): an international survey before and during the COVID-19 pandemic","volume":"12","author":"Luz","year":"2022","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1016\/j.ccc.2025.05.007_bib53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2125.2003.01944.x","article-title":"Bioavailability of dexmedetomidine after extravascular doses in healthy subjects","volume":"56","author":"Anttila","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ccc.2025.05.007_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1264081","article-title":"Intranasal dexmedetomidine vs. oral midazolam for premedication in children: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Pediatr"},{"issue":"8","key":"10.1016\/j.ccc.2025.05.007_bib55","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jama.2022.0799","article-title":"Effect of sublingual dexmedetomidine vs placebo on acute agitation associated with bipolar disorder: a randomized clinical trial","volume":"327","author":"Preskorn","year":"2022","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ccc.2025.05.007_bib56","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00228-015-1913-0","article-title":"Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects","volume":"71","author":"Yoo","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.ccc.2025.05.007_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/cc10518","article-title":"Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients","volume":"15","author":"Iirola","year":"2011","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.ccc.2025.05.007_bib58","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jclinane.2015.06.002","article-title":"Effects of mild hypoalbuminemia on the pharmacokinetics and pharmacodynamics of dexmedetomidine in patients after major abdominal or thoracic surgery","volume":"27","author":"Zhang","year":"2015","journal-title":"J Clin Anesth"},{"issue":"4","key":"10.1016\/j.ccc.2025.05.007_bib59","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<519::AID-JPS9>3.0.CO;2-U","article-title":"Influence of cardiac output on dexmedetomidine pharmacokinetics","volume":"89","author":"Dutta","year":"2000","journal-title":"J Pharmaceut Sci"},{"issue":"5","key":"10.1016\/j.ccc.2025.05.007_bib60","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00000539-200111000-00031","article-title":"The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment","volume":"93","author":"De Wolf","year":"2001","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib61","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/PCC.0000000000002873","article-title":"Society of critical care medicine clinical practice guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility","volume":"23","author":"Smith","year":"2022","journal-title":"Pediatr Crit Care Med"},{"issue":"12","key":"10.1016\/j.ccc.2025.05.007_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70020","article-title":"A systematic review of dexmedetomidine pharmacology in pediatric patients","volume":"17","author":"O'Kane","year":"2024","journal-title":"Clin Transl Sci"},{"issue":"7","key":"10.1016\/j.ccc.2025.05.007_bib63","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00134-022-06712-2","article-title":"Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Lewis","year":"2022","journal-title":"Intensive Care Med"},{"issue":"26","key":"10.1016\/j.ccc.2025.05.007_bib64","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","article-title":"Early sedation with dexmedetomidine in critically ill patients","volume":"380","author":"Shehabi","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ccc.2025.05.007_bib65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00134-021-06356-8","article-title":"Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial","volume":"47","author":"Shehabi","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib66","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13054-023-04618-z","article-title":"Use of dexmedetomidine in critical-ill patients: is it time to look to the actual evidence?","volume":"27","author":"P\u00e9rez-Nieto","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.ccc.2025.05.007_bib67","author":"Agency"},{"issue":"4","key":"10.1016\/j.ccc.2025.05.007_bib68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bja.2022.06.020","article-title":"Outcomes of dexmedetomidine versus propofol sedation in critically ill adults requiring mechanical ventilation: a systematic review and meta-analysis of randomised controlled trials","volume":"129","author":"Kiyan","year":"2022","journal-title":"Br J Anaesth"},{"issue":"15","key":"10.1016\/j.ccc.2025.05.007_bib69","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1056\/NEJMoa2024922","article-title":"Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis","volume":"384","author":"Hughes","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ccc.2025.05.007_bib70","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201710-1995OC","article-title":"Low-dose nocturnal dexmedetomidine prevents ICU delirium. a randomized, placebo-controlled trial","volume":"197","author":"Skrobik","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2025.05.007_bib71","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bja.2024.06.007","article-title":"Effectiveness of dexmedetomidine on patient-centred outcomes in surgical patients: a systematic review and Bayesian meta-analysis","volume":"133","author":"Verret","year":"2024","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bja.2021.11.041","article-title":"Influence of perioperative dexmedetomidine on the incidence of postoperative delirium in adult patients undergoing cardiac surgery","volume":"129","author":"Patel","year":"2022","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.ccc.2025.05.007_bib73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12872-024-03783-5","article-title":"The role of perioperative sedative anesthetics in preventing postoperative delirium: a systematic review and network-meta analysis including 6679 patients","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.ccc.2025.05.007_bib74","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bja.2018.04.046","article-title":"Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials","volume":"121","author":"Duan","year":"2018","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.ccc.2025.05.007_bib75","first-page":"286","article-title":"Efficacy and safety of guanfacine in hospitalized patients with delirium: a scoping review","volume":"26","author":"Pattamin","year":"2024","journal-title":"Crit Care Resusc"},{"issue":"11","key":"10.1016\/j.ccc.2025.05.007_bib76","article-title":"Effect of enteral guanfacine on dexmedetomidine use in the ICU","volume":"4","author":"Fetters","year":"2022","journal-title":"Crit Care Explor"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070425000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070425000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:39:35Z","timestamp":1762310375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070425000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0749070425000417"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2025.05.007","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacology of Alpha-2 Agonists Applied to Sedation, Sleep, and Analgesia","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2025.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}